Tribute Pharmaceuticals Canada Inc. Removed from S&P/TSX Venture Indices
TORONTO , Feb. 4, 2016 /CNW/ - S&P Dow Jones Canadian Index Services will make the following changes in the S&P/TSX Canadian Indices:
The Arrangement Agreement between Tribute Pharmaceuticals Canada Inc. (TRX) and POZEN Inc. (POZN) has been successfully completed. Tribute Pharmaceuticals shareholders will receive 0.1455 shares of a new Canadian-domicile merged entity to be named Aralez Pharmaceuticals Inc. for each share held. Aralez Pharmaceuticals will be listed on TSX and NASDAQ. The shares of Tribute Pharmaceuticals will be removed from the S&P/TSX Venture Select and Venture Composite Indices after the close of trading on Friday, February 5, 2016 .
About S&P Dow Jones Indices
S&P Dow Jones Indices LLC, a part of McGraw Hill Financial, is the world's largest, global resource for index-based concepts, data and research. Home to iconic financial market indicators, such as the S&P 500® and the Dow Jones Industrial Average®, S&P Dow Jones Indices LLC has over 115 years of experience constructing innovative and transparent solutions that fulfill the needs of investors. More assets are invested in products based upon our indices than any other provider in the world. With over 1,000,000 indices covering a wide range of asset classes across the globe, S&P Dow Jones Indices LLC defines the way investors measure and trade the markets. To learn more about our company, please visit www.spdji.com.
S&P® is a registered trademark of Standard & Poor's Financial Services LLC ("S&P"), a part of McGraw Hill Financial. Dow Jones® is a registered trademark of Dow Jones Trademark Holdings LLC ("Dow Jones"). These trademarks have been licensed to S&P Dow Jones Indices LLC. It is not possible to invest directly in an index. S&P Dow Jones Indices LLC, Dow Jones, S&P and their respective affiliates (collectively "S&P Dow Jones Indices") do not sponsor, endorse, sell, or promote any investment fund or other investment vehicle that is offered by third parties and that seeks to provide an investment return based on the performance of any index. This document does not constitute an offer of services in jurisdictions where S&P Dow Jones Indices does not have the necessary licenses. S&P Dow Jones Indices receives compensation in connection with licensing its indices to third parties.
SOURCE S&P Dow Jones Indices
- Dow Jones